Amphastar Pharmaceuticals Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.3 (market cap $826.08M), while Direxion Daily Semiconductor Bear 3X Shares trades at $4.54. The key difference: Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, Direxion Daily Semiconductor Bear 3X Shares nearer its low. Which is the better fit depends on your goals.
| AMPH | SOXS | |
|---|---|---|
Market Cap | $826.08M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $30.81 | $160.60 |
52-Week Low | $16.87 | $3.25 |
Enterprise Value | $1.22B | — |
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
SOXS, the Direxion Daily Semiconductor Bear 3X Shares ETF, trades at $4.08 with minimal daily movement (+0.25%). Technical indicators show a bearish trend with moving averages signaling strong selling pressure, while oscillators remain neutral. The ETF is preparing for a 1:10 stock split effective July 15, 2026, and declared a $0.04 dividend for H1-2026. Recent news highlights the challenging environment for bearish semiconductor bets amid an ongoing AI-driven chip rally that has pressured inverse ETFs.
The outlook for SOXS remains highly speculative and risky, suitable only for sophisticated traders seeking short-term inverse exposure to semiconductors. The primary opportunity lies in potential semiconductor sector volatility or correction, while significant risks include continued AI-driven bullish momentum and the structural decay inherent in leveraged inverse ETFs during sustained market trends.
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →